The Blade: Pandemic has Trump's Ohio rallies on hold until ...?
UC expert David Niven calls political rallies 'theater' that might be lost during pandemic
Political rallies are the perfect stew of everything health officials have warned against to prevent the spread of coronavirus. Dense crowds. Stuffy indoor venues. Lines too long for social distancing. Plenty of vocalizing.
Calling these rallies “theater,” UC faculty member and political expert David Niven comments in The Blade on how coronavirus will impact political campaigns during election season.
“An awful lot of what goes into a campaign is still going to happen, but the theater part, the part that we see, the noisiest and most exciting part, is going to be missing,” says Niven.
Niven teaches American politics in UC's Department of Political Science in the College of Arts and Sciences and conducts research on campaigns, political communication and death penalty policy.
Featured image of Trump at a political rally. Photo/The Blade
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.